Eligibility Details:  
        Inclusion Criteria:
          -  Body Mass Index (BMI) 18.5 - 29.9 kg/m2
        Exclusion Criteria:
          -  Has HIV/AIDS or another disease that affects the immune system
          -  Has any kind of cancer
          -  Decline to take an HIV blood test
          -  Blood pressure greater than or equal to 140/90 mmhg
          -  Pregnant or lactating women
          -  Refusal to take a pregnancy test prior to the study
          -  Refusal to use a method of birth control during the study
          -  Allergy to vaccine components, i.e. Thimerosal and enteric-coated capsules
          -  Allergy to oral typhoid vaccine
          -  Allergy to aspirin
          -  Daily use of blood thinners
          -  Use of anti-inflammatory medications, i.e. nonsteroidal anti-inflammatory drugs
             (NSAID), aspirin, 3 or more times per month
          -  Use of sulfonamides or antibiotics in the past 30 days
          -  Use of anti-hypertensive drugs, i.e. beta blockers, diuretics, calcium channel
             blockers
          -  Use of anti-malaria drugs, i.e. Mefloquine, chloroquine, and proguanil
          -  Use of drugs that affect the immune system, i.e. immunosuppressants, immune-modifying
             drugs, corticosteroids, i.e. cortisone, prednisone, methylprednisolone, for 2 weeks or
             longer
          -  Is taking cancer treatment with radiation or drugs
          -  Greater than ten years residence in a typhoid-endemic area
          -  Receipt of typhoid vaccine in the last 5 years
          -  Receipt of any vaccine two weeks prior to receipt of Ty21a vaccine
          -  Individuals at increased risk of developing complications from a live, bacterial
             vaccine
          -  History of typhoid fever
          -  History of primary immune deficiency or autoimmune disease
          -  History of acute or chronic gastrointestinal (GI) disorder, i.e. Crohn's disease,
             irritable bowel syndrome, gastric ulcer
          -  Diarrheal illness (defined as passing 3 or more abnormally loose or watery stool in a
             24 hour period) or persistent vomiting 2 weeks prior to the study
          -  History of bleeding disorder, including bleeding from the GI tract
          -  History of chronic illnesses, i.e. diabetes, cardiovascular disease, cancer,
             gastrointestinal malabsorption or inflammatory diseases, kidney disease, autoimmune
             disorders, HIV, liver disease, including hepatitis B and C.
          -  Asthma if taking medication on a daily basis
          -  Recent surgery (within 3 months)
          -  History of GI surgery
          -  Recent hospitalization (within 3 months)
          -  Acute febrile illness (within 2 weeks)
          -  Unwillingness to discontinue consumption of artificial sweeteners in foods or drinks,
             i.e. sport drinks, coconut water, "diet" drinks and foods (possibly containing
             sucralose)
          -  Not having at least one arm vein suitable for blood drawing
          -  Unwilling or uncomfortable with blood draws seven times in 29 days
          -  Regular blood or blood product donation and refusal to suspend donation
          -  Current participation in another research study
          -  Unable to fast for 12-16 hours